Cumberland Pharmaceuticals CPIX
NASDAQ CPIX
$6.32 -0.30 (-4.45%)
As of: Sep 9, 2026 · 1:19 PM EDT

Cumberland Pharmaceuticals (CPIX) Shares Outstanding (2010 - 2026)

Cumberland Pharmaceuticals' (CPIX) quarterly Shares Outstanding (Entity) came in at $15.0 million in Q2 2026, little changed year-over-year from $15.0 million in Q2 2025, and little changed quarter-over-quarter from $15.0 million in Q1 2026.

Analysis

Cumberland Pharmaceuticals (CPIX) Shares Outstanding (2010 - 2026) Analysis & Trends

Cumberland Pharmaceuticals has disclosed Shares Outstanding (Entity) across 17 years of filings, most recently posting $15.0 million for Q2 2026.

  • In Q2 2026, Shares Outstanding (Entity) changed 0.15% year-over-year to $15.0 million; the TTM figure through Jun 2026 stood at $15.0 million (changed 0.15% YoY), while the FY2025 annual figure was $15.0 million, up 7.2% from the prior year.
  • Shares Outstanding (Entity) came in at $15.0 million for Q2 2026 at Cumberland Pharmaceuticals, roughly flat from $15.0 million in the prior quarter.
  • In the past five years, Shares Outstanding (Entity) ranged from a high of $15.0 million in Q1 2026 to a low of $14.0 million in Q4 2024.
  • Average Shares Outstanding (Entity) over 5 years is $14.5 million, with a median of $14.4 million recorded in 2022.
  • Year-over-year, Shares Outstanding (Entity) retreated 2.79% in 2022 and rose 7.2% in 2025.
  • Over 5 years, Shares Outstanding (Entity) stood at $14.4 million in 2022, then dropped by 1.7% to $14.1 million in 2023, then dropped by 1.2% to $14.0 million in 2024, then gained by 7.2% to $15.0 million in 2025, then grew by 0.18% to $15.0 million in 2026.
  • Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $15.0 million in Q2 2026, $15.0 million in Q1 2026, and $15.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Johnson & Johnson 645.04 Bn 624.28 Bn 17.26 Bn 2.41 Bn
2 AbbVie 440.25 Bn 433.68 Bn 12.70 Bn 1.77 Bn
3 Merck 365.65 Bn 358.51 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 266.64 Bn 258.95 Bn 11.24 Bn 1.94 Bn
5 Pfizer 159.03 Bn 147.33 Bn 10.94 Bn 5.70 Bn
6 Sanofi 52.43 Bn 45.05 Bn 10.79 Bn 1.22 Bn
7 Revolution Medicines 44.19 Bn 44.19 Bn - 210.89 Mn
8 Incyte 25.29 Bn 20.75 Bn 1.57 Bn 200.38 Mn
9 United Therapeutics 21.44 Bn 18.77 Bn 683.80 Mn 42.60 Mn
10 Cumberland Pharmaceuticals 94.76 Mn 90.90 Mn - 14.98 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14.98 Mn
Mar 31, 2026 14.96 Mn
Dec 31, 2025 14.85 Mn
Sep 30, 2025 14.96 Mn
Jun 30, 2025 14.96 Mn
Mar 31, 2025 14.94 Mn
Dec 31, 2024 14.06 Mn
Sep 30, 2024 14.05 Mn
Jun 30, 2024 14.12 Mn
Mar 31, 2024 14.10 Mn
Dec 31, 2023 14.30 Mn
Sep 30, 2023 14.28 Mn
Jun 30, 2023 14.39 Mn
Mar 31, 2023 14.36 Mn
Dec 31, 2022 14.56 Mn
Sep 30, 2022 14.48 Mn
Jun 30, 2022 14.69 Mn
Mar 31, 2022 14.69 Mn
Dec 31, 2021 14.90 Mn
Sep 30, 2021 14.88 Mn